-
Admin
Successful Submission of Start-Up Biotech Investigational New Drug Application
So proud of the team that made this significant accomplishment…
-
Admin
See You at the Rare Disease Research Symposium 2019
Join us on Tuesday, September 24 at the Rare Disease Research…
-
Admin
Want to apply for NIH funding, but not sure where to start?
We’re proud to collaborate with the Westchester Biotech Project on…
-
Admin
‘Thank You’ for Attending ACRP Presentations!
3Sixty Pharma Solutions’ CEO on Communicating with Savvy during ACRP2019 Rapid-Fire…
-
Admin
Great Conversations at ACRP in Nashville!
We enjoyed meeting you at ACRP in Nashville last week!…
Latest Posts
Categories
- Best Practices
- Change Management
- Clinical
- Clinical Trials
- Collaboration
- Communication
- Complexity
- Governance
- International Clinical Trials Day
- Leadership
- Marketing
- Medical Education
- MSL
- Patient-centered
- Pharma News
- PMOs
- Portfolio Management
- Program Management
- Project Management
- Project Management Salaries
- Project/Program/Portfolio Management
- Recruiting
- Salaries
- Uncategorized
Tags
3SixtyPharma Alzheimer's Anti-IgE anti-inflammatory anti-TNF anti-TNF-? B-cell Biosimilar clinical clinical research CNS Communication CT-P13 DEMENTIA FDA gastrointestinal genome GI Inflammation Inflectra infliximab interchangeability investigational JAK inhibitor KTE-C19 Lymphoma oncology patients Pharma Portfolio Management Program Management Project Management rare disease remote Remsima rheumatoid arthritis spondyloarthritis switching Theravance Biopharma virtual w webinar White House White House Office of Management and Budget White House OMB